Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX · NASDAQ Global Select
-$0.05 today
Vol 3.77M · Avg 2.48M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+173.80%
Period High
$2.44
Period Low
$0.73
Latest
$2.01
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
RAPT Therapeutics, Inc.
RAPT
$959.26M
Omeros Corporation
NASDAQ:OMER
$732.80M
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
$500.81M
Ocugen, Inc.
NASDAQ:OCGN
$428.23M
Compass Therapeutics, Inc.
NASDAQ:CMPX
$281.41M
Bicycle Therapeutics plc
NASDAQ:BCYC
$277.23M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$268.92M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$188.85M
ADC Therapeutics S.A.
NYSE:ADCT
$138.64M
Gossamer Bio, Inc.
GOSS
$39.29M
What is the latest LXRX filing?
The latest filing shown is 4 dated Jun 4, 2026.
How many recent filings does LXRX have?
Intrinsic Alpha currently shows 20 recent filings for LXRX.
Explore More
Continue the stock analysis
Jump to another research area for this company.